Form 4: TFS Financial CFO Plans Future Stock Sale
Insider Transaction Report
TFS Financial's Chief Financial Officer, Meredith S. Weil, filed a Form 4 indicating a planned sale of 15,000 common shares in September 2025.
Summary
- Meredith S. Weil, Chief Financial Officer and Director of TFS Financial CORP (TFSL), filed a Form 4 reporting a planned transaction.
- The filing indicates a disposition (sale) of 15,000 shares of common stock at a price of $13.70 per share, scheduled for September 2, 2025.
- This transaction is made pursuant to a Rule 10b5-1(c) contract, indicating it is a pre-scheduled plan.
- Following the planned transaction, Ms. Weil will directly own 63,527 shares of common stock, with shared voting power with her spouse.
- Indirect beneficial ownership includes 364 shares via a 401(k) plan and 538 shares via an ESOP.
- Ms. Weil also holds significant derivative securities, including 19,170 Performance Restricted Share Units (PSUs) earned from a December 2022 award, vesting on December 10, 2025.
- Additional Restricted Stock Units (RSUs) include 16,600 units granted December 19, 2024, vesting in three equal annual installments starting December 10, 2025.
- Other RSU holdings include 9,600 units from a March 2024 grant (vesting started December 10, 2024), 4,734 units from a December 2022 grant (vesting started December 10, 2023), and 3,600 units from a September 2011 grant (vesting started May 14, 2011, distributed upon termination).
- Employee Stock Options include 187,500 options with an exercise price of $14.74 expiring January 5, 2028, 54,400 options with an exercise price of $19.31 expiring December 15, 2026, and 24,200 options with an exercise price of $19.06 expiring December 17, 2025.
Sentiment
Score: 6
Explanation: The planned sale of shares by a key executive, while a reduction in direct holdings, is made pursuant to a Rule 10b5-1(c) plan, suggesting a pre-scheduled diversification rather than an opportunistic sale. The executive retains substantial equity holdings and future vesting awards.
Positives
- The reporting person has earned 19,170 Performance Share Units (PSUs) by achieving 90.0% of a target award, demonstrating successful performance against set metrics.
- Significant grants of Restricted Stock Units (RSUs) and Employee Stock Options indicate ongoing long-term incentive alignment with company performance and shareholder value.
- The retention of substantial unvested equity awards and stock options suggests continued commitment to the company's future success.
Negatives
- The Chief Financial Officer plans to sell 15,000 shares of common stock, which reduces her direct equity stake in the company.
Future Outlook
The filing outlines a future planned sale of common stock by the CFO in September 2025, alongside various vesting schedules for Performance Share Units and Restricted Stock Units, and expiration dates for Employee Stock Options extending through 2028. These indicate future equity-related events for the reporting person.
Industry Context
This Form 4 filing is a routine disclosure of an insider's planned equity transaction and holdings. It does not provide broader industry context or trends, but rather reflects an individual executive's personal financial planning and compensation structure within the financial services sector.
Stakeholder Impact
- Shareholders may interpret the planned insider sale as a signal, though its pre-scheduled nature under a 10b5-1 plan mitigates concerns about opportunistic selling.
- The executive's continued significant holdings in unvested equity awards and stock options suggest ongoing alignment with long-term shareholder interests.
Next Steps
- The planned sale of 15,000 common shares by Meredith S. Weil is scheduled for September 2, 2025.
- 19,170 Performance Share Units are scheduled to vest and distribute on December 10, 2025.
- 16,600 Restricted Stock Units granted on December 19, 2024, will begin vesting in three equal annual installments starting December 10, 2025.
- Remaining Restricted Stock Units and Employee Stock Options will continue to vest or expire according to their respective schedules.
Key Dates
| Date | Description |
|---|---|
| 05/14/2011 | Start of vesting for 3,600 Restricted Stock Units granted on September 29, 2011. |
| 09/29/2011 | Grant date for 3,600 Restricted Stock Units. |
| 12/15/2015 | Grant date for 49,200 Employee Stock Options. |
| 12/17/2015 | Form 4 filing date for the 49,200 Employee Stock Options grant. |
| 12/10/2016 | Start of vesting for 49,200 Employee Stock Options granted on December 15, 2015. |
| 12/15/2016 | Grant date for 79,400 Employee Stock Options. |
| 12/10/2017 | Start of vesting for 79,400 Employee Stock Options granted on December 15, 2016. |
| 01/08/2018 | Form 4 filing date for the 187,500 Employee Stock Options grant. |
| 12/10/2018 | Start of vesting for 187,500 Employee Stock Options granted on January 8, 2018. |
| 12/15/2022 | Grant date for 14,200 Restricted Stock Units. |
| 12/10/2023 | Start of vesting for 14,200 Restricted Stock Units granted on December 15, 2022. |
| 03/04/2024 | Grant date for 14,400 Restricted Stock Units. |
| 09/30/2024 | End of the two fiscal year performance period for Performance Share Units. |
| 11/21/2024 | Determination date for 19,170 Performance Share Units earned from a target award of 21,300. |
| 12/10/2024 | Start of vesting for 14,400 Restricted Stock Units granted on March 4, 2024. |
| 12/19/2024 | Grant date for 16,600 Restricted Stock Units. |
| 09/02/2025 | Planned transaction date for the sale of 15,000 common shares. |
| 09/04/2025 | Filing date of this Form 4. |
| 12/10/2025 | Start of vesting for 16,600 Restricted Stock Units granted on December 19, 2024. |
| 12/10/2025 | Vesting and distribution date for 19,170 Performance Share Units. |
| 12/17/2025 | Expiration date for 24,200 Employee Stock Options granted on December 15, 2015. |
| 12/15/2026 | Expiration date for 54,400 Employee Stock Options granted on December 15, 2016. |
| 01/05/2028 | Expiration date for 187,500 Employee Stock Options granted on January 8, 2018. |
Recommendation
holdThe planned sale of 15,000 shares by the CFO is a pre-scheduled transaction under a Rule 10b5-1 plan, which typically indicates a diversification strategy rather than a negative outlook on the company. The executive maintains significant beneficial ownership, including substantial unvested equity awards, suggesting continued alignment with shareholder interests. Therefore, a 'hold' recommendation is appropriate, advising investors to monitor future company performance and insider activity.
Keywords
TFS Financial, TFSL, Form 4, Insider Trading, Stock Sale, CFO, Meredith S. Weil, Equity Compensation, Restricted Stock Units, Stock Options, Performance Share Units, 10b5-1 Plan
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.